Blogs

Categories

Select a sub-category to view results

Icon
Films and Coatings
vail 4ml
Pharmaceutical Packaging Components
Icon
Prefillable Systems
Icon
Self Injection Devices
Icon
Vial Containment Solutions
Icon
Washing and Sterilization
Icon
Reconstitution and Transfer Devices

Select a sub-category to view results

Icon
Analytical Lab Services
Icon
Contract Manufacturing
Icon
Fill-Finish
Icon
Regulatory Support

Select a sub-category to view results

Icon
Cell and Gene Therapy Packaging
Icon
Drug Development Process
Icon
Regulatory Challenges
Icon
Transitioning to Combination Products

Select a sub-category to view results

Icon
Corporate Development
Icon
ESG/Sustainability
Icon
One West Team (Employee Culture)
Icon
Our Culture of Giving (Philanthropy)
Icon
Research and Development

Previous Blogs

BioPharma Summit

By Candice Sun

September 09, 2019

China has now stepped into its “golden age” of biopharma; this year regulators approved the country’s first biosimilar product, HLX01.  Developed by Shanghai Henlius Biotech, it will be used primarily for treatment of non-Hodgkin’s lymphoma.  Biologics are sensitive large molecules, so selecting the appropriate packaging and delivery system is critical.  To this end, West Pharmaceutical Services, Inc. (“West”) recently held China BioPharma Summit for Injectable Drug Packaging and Delivery Systems in Suzhou.  Over 200 persons attended.